Your browser doesn't support javascript.
loading
BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance.
Tarantelli, Chiara; Bernasconi, Elena; Gaudio, Eugenio; Cascione, Luciano; Restelli, Valentina; Arribas, Alberto Jesus; Spriano, Filippo; Rinaldi, Andrea; Mensah, Afua Adjeiwaa; Kwee, Ivo; Ponzoni, Maurilio; Zucca, Emanuele; Carrassa, Laura; Riveiro, Maria E; Rezai, Keyvan; Stathis, Anastasios; Cvitkovic, Esteban; Bertoni, Francesco.
  • Tarantelli C; Università della Svizzera italiana (USI), Institute of Oncology Research (IOR), Bellinzona, Switzerland.
  • Bernasconi E; Università della Svizzera italiana (USI), Institute of Oncology Research (IOR), Bellinzona, Switzerland.
  • Gaudio E; Università della Svizzera italiana (USI), Institute of Oncology Research (IOR), Bellinzona, Switzerland.
  • Cascione L; Università della Svizzera italiana (USI), Institute of Oncology Research (IOR), Bellinzona, Switzerland.
  • Restelli V; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.
  • Arribas AJ; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
  • Spriano F; Università della Svizzera italiana (USI), Institute of Oncology Research (IOR), Bellinzona, Switzerland.
  • Rinaldi A; Università della Svizzera italiana (USI), Institute of Oncology Research (IOR), Bellinzona, Switzerland.
  • Mensah AA; Università della Svizzera italiana (USI), Institute of Oncology Research (IOR), Bellinzona, Switzerland.
  • Kwee I; Università della Svizzera italiana (USI), Institute of Oncology Research (IOR), Bellinzona, Switzerland.
  • Ponzoni M; Università della Svizzera italiana (USI), Institute of Oncology Research (IOR), Bellinzona, Switzerland.
  • Zucca E; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.
  • Carrassa L; Dalle Molle Institute for Artificial Intelligence (IDSIA), Manno, Switzerland.
  • Riveiro ME; Department of Onco-Haematology, Unit of Lymphoid Malignancies, San Raffaele Scientific Institute, Milan, Italy.
  • Rezai K; IOSI Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Stathis A; IRCCS-Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
  • Cvitkovic E; OTD Oncology, Therapeutic Development, Clichy, France.
  • Bertoni F; Institut Curie, Hôpital René Huguenin, Saint-Cloud, France.
ESMO Open ; 3(6): e000387, 2018.
Article en En | MEDLINE | ID: mdl-30305939
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Año: 2018 Tipo del documento: Article